IRCT20181208041886N1招募中未知
Evaluation of levamizole on treatment of patients with COVID 19 infection: a controlled clinical trial study.
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •age =or > 18 years
- •Diagnosis of COVID19 infection was made by positive test for RtPCR on nasopharyngeal swab, Lung HRCT and the opinion of infectious diseases specialist.
- •informed consent of patient for study
- •the possibility of patient follow up.
排除标准
- •Another cause for signs and symptoms
- •hypersensitivity to levamizole
- •consumption of other antibiotics on the neck.
- •breat feeding
研究者
相似试验
已完成
3 期
Efficacy of Levamisol in Treating COVID-19IRCT20201124049480N1Artesh University of Medical Sciences365
已完成
2 期
Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic PatientsOnchocerciasis, OcularLoiasisNCT04049630Programme National de Lutte contre l'Onchocercose, Republic of the Congo255
已完成
2 期
evamizole effect on mortality reduction in patients with more than 50% burn of body surface areaIRCT138903044020N1Iran University of Medical Sciences100
进行中（未招募）
1 期
AEUCTR2016-002324-92-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)156
招募中
2 期
Evaluation of Levamisole efficacy in treatment of Covid-19IRCT20190810044500N7Yazd University of Medical Sciences50